Role of p53‐dependent placental apoptosis in the reproductive and developmental toxicities of caffeine in rodents
Authors:
- 26 March 2012
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 39 (4) , 357-363
Abstract
Summary: The aim of the present study was to evaluate the role of placental apoptosis in mediating the reproductive and developmental toxicity of caffeine in rodents. Female Kunming mice were treated with caffeine (60, 120 and 240 mg/kg per day) before and during pregnancy. The conception rate, maternal bodyweight gain, placental weight and indices of fetal developmental, including the rate of intrauterine growth retardation (IUGR; i.e. the actual number of fetuses exhibiting IUGR as a percentage of the total number of fetuses), were determined on gestational day (GD) 18. Female Wistar rats were treated with caffeine (20, 60 and 180 mg/kg per day) from GD11 to GD20. The IUGR rate, maternal plasma angiotensin (Ang) II and prolactin concentrations, placental pathology, expression of angiotensin AT1 and AT2 receptors and apoptosis‐related proteins were measured on GD20. In mice, caffeine treatment dose‐dependently reduced the total conception rate, delayed conception and decreased maternal bodyweight gain, placental weight, fetal bodyweight and fetal body and tail lengths, whereas the IUGR rate was increased. In rats, caffeine treatment dose‐dependently decreased placental weight and fetal bodyweight and increased the IUGR rate. Abnormal placental structures and decreased maternal plasma prolactin concentrations were observed following 180 mg/kg per day caffeine treatment, which resulted in increases in renin–angiotensin system (RAS) activity, including maternal plasma AngII concentrations and placental AT1B and AT2 receptor expression, and Bax and p53 expression, but decreases in placental Bcl‐2 expression. On the basis of the results of the present study, it appears that caffeine ingestion has detrimental effects on the reproductive system and fetal development in rodents that are associated with chronic activation of the maternal and placental RAS, and induction of p53‐dependent placental apoptosis.Keywords
This publication has 30 references indexed in Scilit:
- Pathological assessment of intrauterine growth restrictionBest Practice & Research Clinical Obstetrics & Gynaecology, 2009
- Caffeine in pregnancyArchives of Gynecology and Obstetrics, 2009
- Causes of Intrauterine Growth Restriction and the Postnatal Development of the Metabolic SyndromeAnnals of the New York Academy of Sciences, 2006
- Beneficial Effect of Supplemental Lipoic Acid on Diabetes‐Induced Pregnancy Loss in the MouseAnnals of the New York Academy of Sciences, 2006
- Mechanisms of apoptosis after ischemia and reperfusion: Role of the renin-angiotensin systemApoptosis, 2006
- Body Mass Index, Body Composition, and Leptin at Onset of Puberty in Male and Female Rats after Intrauterine Growth Retardation and after Early Postnatal Food RestrictionPediatric Research, 2001
- Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants.Journal of Clinical Investigation, 1998
- Caffeine Intake and Delayed Conception: A European Multicenter Study on Infertility and SubfecundityAmerican Journal of Epidemiology, 1997
- The Physiology and Pathophysiology of Intrauterine Growth RetardationHormone Research, 1997
- Caffeine consumptionFood and Chemical Toxicology, 1996